blister
发表于 2025-3-25 06:04:51
http://reply.papertrans.cn/24/2312/231141/231141_21.png
motor-unit
发表于 2025-3-25 09:09:24
https://doi.org/10.1007/978-1-4612-4430-1power over a patented technology or product. This result indicates that no challenge clauses should only be illegal when both preconditions are met. The Japan Fair Trade Commission’s approach to these clauses is largely consistent with these important theoretical insights.
Petechiae
发表于 2025-3-25 15:28:33
http://reply.papertrans.cn/24/2312/231141/231141_23.png
率直
发表于 2025-3-25 19:33:15
Vikash Gupta,Gautam Prasad,Paul Thompsonto adapt to these systemic changes. In the second half of the chapter, I describe the contributions of science to innovation in drug discovery and the relationship between patent protection and competition in the pharmaceutical industry, based on case studies of the development of 14 drugs created by Japanese pharmaceutical companies.
高歌
发表于 2025-3-25 21:52:01
http://reply.papertrans.cn/24/2312/231141/231141_25.png
cancellous-bone
发表于 2025-3-26 00:53:17
No Challenge Clauses in the Pharmaceutical Industry in Japanpower over a patented technology or product. This result indicates that no challenge clauses should only be illegal when both preconditions are met. The Japan Fair Trade Commission’s approach to these clauses is largely consistent with these important theoretical insights.
惩罚
发表于 2025-3-26 04:47:17
http://reply.papertrans.cn/24/2312/231141/231141_27.png
正论
发表于 2025-3-26 09:03:51
http://reply.papertrans.cn/24/2312/231141/231141_28.png
大约冬季
发表于 2025-3-26 15:56:28
http://reply.papertrans.cn/24/2312/231141/231141_29.png
Regurgitation
发表于 2025-3-26 16:49:27
Imaging Flow Cytometry of Multi-Nuclearitytional Health Insurance (NHI) drug price standard, the official price list for medicines in Japan. In this way, the patent system and the pharmaceutical regulations work together to provide incentives to create pharmaceuticals.